Access Bio Inc (950130) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.015x

Based on the latest financial reports, Access Bio Inc (950130) has a cash flow conversion efficiency ratio of -0.015x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-9.16 Billion ≈ $-6.21 Million USD) by net assets (₩599.93 Billion ≈ $406.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 950130 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Access Bio Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Access Bio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Access Bio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Access Bio Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
K2 Gold Corporation V:KTO	-0.009x
Spring Valley Acquisition Corp. II Class A Ordinary Shares NASDAQ:SVII	-0.031x
China National Accord Medicines Corp Ltd SHE:200028	-0.019x
Avaco Co. Ltd KQ:083930	0.014x
Caisse Régionale du Crédit Agricole Alpes Provence PA:CRAP	0.041x
Igis Value Plus Reit Co Ltd KO:334890	N/A
Business Online PCL BK:BOL	0.012x
Arihant Superstructures Limited NSE:ARIHANTSUP	-0.215x

Annual Cash Flow Conversion Efficiency for Access Bio Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Access Bio Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 950130 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩442.28 Million ≈ $299.73K	₩13.54 Million ≈ $9.18K	0.031x	+22410.95%
2023-12-31	₩587.14 Billion ≈ $397.90 Million	₩-80.57 Million ≈ $-54.60K	0.000x	-100.02%
2022-12-31	₩487.74 Million ≈ $330.53K	₩291.33 Million ≈ $197.43K	0.597x	+4.71%
2021-12-31	₩241.75 Million ≈ $163.83K	₩137.90 Million ≈ $93.45K	0.570x	-99.88%
2020-12-31	₩76.95 Million ≈ $52.15K	₩36.72 Billion ≈ $24.89 Million	477.222x	+2498.24%
2019-12-31	₩21.22 Million ≈ $14.38K	₩-422.24 Million ≈ $-286.15K	-19.899x	+88.40%
2018-12-31	₩33.42 Million ≈ $22.65K	₩-5.73 Billion ≈ $-3.88 Million	-171.471x	-29.50%
2017-12-31	₩41.13 Million ≈ $27.87K	₩-5.45 Billion ≈ $-3.69 Million	-132.408x	-298039.61%
2016-12-31	₩47.55 Million ≈ $32.22K	₩2.11 Million ≈ $1.43K	0.044x	+19.26%
2015-12-31	₩76.88 Billion ≈ $52.10 Million	₩2.87 Billion ≈ $1.94 Million	0.037x	+197.03%
2014-12-31	₩68.58 Billion ≈ $46.48 Million	₩-2.63 Billion ≈ $-1.79 Million	-0.038x	-221.48%
2013-12-31	₩50.20 Billion ≈ $34.02 Million	₩1.59 Billion ≈ $1.08 Million	0.032x	-62.82%
2012-12-31	₩21.71 Billion ≈ $14.71 Million	₩1.85 Billion ≈ $1.25 Million	0.085x	--

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$125.38 Million

₩185.01 Billion KRW

Market Cap Rank

#18422 Global

#836 in Korea

Share Price

₩5260.00

Change (1 day)

-1.31%

52-Week Range

₩5140.00 - ₩5690.00

All Time High

₩29950.00